Capital Management Corp VA Acquires 146,688 Shares of Concentrix Corporation $CNXC

Capital Management Corp VA grew its holdings in shares of Concentrix Corporation (NASDAQ:CNXCFree Report) by 45.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 472,681 shares of the company’s stock after buying an additional 146,688 shares during the period. Concentrix accounts for about 3.4% of Capital Management Corp VA’s holdings, making the stock its 10th largest holding. Capital Management Corp VA’s holdings in Concentrix were worth $21,814,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in CNXC. Geneos Wealth Management Inc. lifted its stake in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the last quarter. Quent Capital LLC purchased a new position in Concentrix in the third quarter valued at approximately $29,000. IFP Advisors Inc raised its holdings in Concentrix by 473.8% during the second quarter. IFP Advisors Inc now owns 700 shares of the company’s stock worth $37,000 after purchasing an additional 578 shares in the last quarter. True Wealth Design LLC lifted its position in shares of Concentrix by 39.3% during the 2nd quarter. True Wealth Design LLC now owns 1,163 shares of the company’s stock worth $61,000 after buying an additional 328 shares during the last quarter. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of Concentrix by 23.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,818 shares of the company’s stock valued at $96,000 after buying an additional 351 shares in the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Price Performance

Shares of NASDAQ:CNXC opened at $37.35 on Friday. Concentrix Corporation has a one year low of $31.63 and a one year high of $66.00. The stock has a market capitalization of $2.30 billion, a price-to-earnings ratio of -1.79, a PEG ratio of 0.41 and a beta of 0.48. The company has a 50-day simple moving average of $40.08 and a 200-day simple moving average of $45.30. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.56 and a current ratio of 1.40.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The firm had revenue of $2.55 billion for the quarter, compared to analysts’ expectations of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. On average, analysts predict that Concentrix Corporation will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 10th. Stockholders of record on Friday, January 30th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 3.9%. Concentrix’s payout ratio is presently -6.91%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on CNXC shares. Weiss Ratings lowered shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday. Robert W. Baird set a $52.00 price objective on Concentrix in a report on Wednesday, January 14th. Wall Street Zen cut Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, January 17th. Finally, Barrington Research reissued an “outperform” rating and issued a $62.00 target price on shares of Concentrix in a research report on Monday, January 12th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Concentrix has a consensus rating of “Hold” and an average price target of $63.75.

View Our Latest Report on CNXC

About Concentrix

(Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Stories

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXCFree Report).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.